Pennant Group, Inc.(PNTG)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,102 of 2,879 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
PNTG Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Pennant Group, Inc. (PNTG), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PNTG at 56.4/100 on a 32-signal composite quality model, placing it at rank #1,102 of 2,879 stocks — the top half of the AI-ranked universe. PNTG scores in the top quartile across revenue growth (87.6), earnings quality (82.7). Areas of concern include institutional flow (15.1) and free cash flow (37.1), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Pennant Group, Inc. reports quarterly revenue of $285.4M, net income of $8.5M, an operating margin of 6.1%. Top institutional holders of PNTG by reported 13-F value include BlackRock,, Turtle Creek Asset Management, WASATCH ADVISORS, based on the most recent SEC filings. PNTG trades on the Nasdaq exchange and files with the SEC under CIK 1766400. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PNTG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Pennant Group, Inc. directly from SEC EDGAR. Pennant Group, Inc.'s 13F Pro composite quality score has ranged between 8 and 70 since 2021, currently 56.4 — a stable long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q1 2026
$285.4M
Net Income
Q1 2026
$8.5M
Free Cash Flow
Q1 2026
$-8.7M
Operating Margin
Q1 2026
6.1%
ROIC
Q1 2026
3.1%
D/E Ratio
Q1 2026
0.44
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+36.3% YoYNet Income
+31.1% YoYOperating Income
+36.1% YoYEPS (Diluted)
+20.0% YoYTotal Assets
+42.5% YoYTotal Debt
Op. Cash Flow
+22.9% YoY| Metric | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2018 |
|---|---|---|---|---|---|---|
| Revenue | $947.7M +36.3% | $695.2M +46.9% | $473.2M +7.6% | $439.7M +12.5% | $391.0M +36.7% | $286.1M |
| Net Income | $29.6M +31.1% | $22.6M +239.6% | $6.6M +146.4% | $2.7M -82.9% | $15.7M +0.4% | $15.7M |
| Operating Income | $51.9M +36.1% | $38.1M +199.2% | $12.7M +171.3% | $4.7M -75.2% | $18.9M -8.3% | $20.6M |
| EPS (Diluted) | $0.84 +20.0% | $0.70 +218.2% | $0.22 +144.4% | $0.09 -82.7% | $0.52 -10.3% | $0.58 |
| Total Assets | $968.2M +42.5% | $679.5M +32.7% | $512.1M -3.4% | $530.3M +4.6% | $507.0M +416.5% | $98.2M |
| Total Debt | $173.8M | $0.00 -100.0% | $62.9M +22.4% | $51.4M +520.7% | $8.3M | $0.00 |
| Operating Cash Flow | $48.3M +22.9% | $39.3M +334.5% | $9.0M +149.6% | $-18.2M -136.3% | $50.2M +115.7% | $23.3M |
AI Insight: PNTG Ratio Trends
PNTG's operating margin recovered to 6.1% in Q1 2026 after a Q3 2025 trough, but profitability remains range-bound with no clear expansion trend.
• Operating margin dipped to 4.5% in Q3 2025 before recovering to 6.0% in Q4 2025 and 6.1% in Q1 2026, suggesting seasonal softness rather than structural deterioration.
• Net profit margin has stayed in a narrow 2.7%–3.7% band across all reported quarters, indicating limited earnings leverage on revenue.
• ROA declined from 4.2% in Q1 2025 to 3.2% in Q3 2025, recovering modestly to 3.6% in Q1 2026 — still below the prior-year peak.
⚠ ROIC swung from 96.4% in Q1 2025 to 40.8% in Q1 2026 and is missing for three quarters — data gaps obscure capital efficiency trends.
⚠ Q3 2025 saw the weakest margins across all metrics; whether that seasonal pattern repeats in Q3 2026 is a key inflection to monitor.
Get alerted when PNTG's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Pennant Group, Inc. including:
Top Institutional Holders of PNTG
BlackRock, Inc.
$82.8M2,716,065 shTurtle Creek Asset Management Inc.
$48.2M1,582,823 shWASATCH ADVISORS LP
$43.2M1,418,687 shPARADIGM CAPITAL MANAGEMENT INC/NY
$42.9M1,408,800 shFMR LLC
$33.6M1,102,624 shProvident Investment Management, Inc.
$30.0M983,015 shOphir Asset Management Pty Ltd
$27.6M903,881 shAMERIPRISE FINANCIAL INC
$26.6M872,185 shGEODE CAPITAL MANAGEMENT, LLC
$25.7M842,138 shDIMENSIONAL FUND ADVISORS LP
$24.9M815,660 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $82.8M | 2,716,065 |
| Turtle Creek Asset Management Inc. | $48.2M | 1,582,823 |
| WASATCH ADVISORS LP | $43.2M | 1,418,687 |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $42.9M | 1,408,800 |
| FMR LLC | $33.6M | 1,102,624 |
| Provident Investment Management, Inc. | $30.0M | 983,015 |
| Ophir Asset Management Pty Ltd | $27.6M | 903,881 |
| AMERIPRISE FINANCIAL INC | $26.6M | 872,185 |
| GEODE CAPITAL MANAGEMENT, LLC | $25.7M | 842,138 |
| DIMENSIONAL FUND ADVISORS LP | $24.9M | 815,660 |
More Healthcare Companies
View all Healthcare →Put PNTG on your watchlist
Track score changes the day Pennant Group, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is PNTG a good stock to buy?
13F Pro's AI-powered analysis of Pennant Group, Inc. (PNTG) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PNTG are available on the PNTG stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own PNTG?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PNTG. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Pennant Group, Inc.'s investment landscape.